← TENET HEALTHCARE CORP
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $716.0m | $611.0m | $411.0m | $262.0m | $2.4b | $2.4b | $858.0m | $1.2b | $3.0b | $2.9b | |
| Cash and cash equivalents | $716.0m | $611.0m | $411.0m | $262.0m | $2.4b | $2.4b | $858.0m | $1.2b | $3.0b | $2.9b | |
| Accounts receivable | $2.9b | $2.6b | $2.6b | $2.7b | $2.7b | $2.8b | $2.9b | $2.9b | $2.5b | $2.6b | |
| Inventories of supplies, at cost | $326.0m | $289.0m | $305.0m | $310.0m | $368.0m | $384.0m | $405.0m | $411.0m | $346.0m | $348.0m | |
| Other current assets | $1.3b | $1.0b | $1.2b | $1.4b | $1.5b | $1.6b | $1.8b | $1.8b | $1.8b | $2.0b | |
| Inventory, Net | $326.0m | $289.0m | $305.0m | $310.0m | $368.0m | $384.0m | $405.0m | $411.0m | $346.0m | $348.0m | |
| Assets, Current | $5.3b | $5.6b | $4.6b | $5.1b | $7.1b | $7.1b | $6.0b | $7.2b | $7.7b | $7.8b | |
| Total current assets | $5.3b | $5.6b | $4.6b | $5.1b | $7.1b | $7.1b | $6.0b | $7.2b | $7.7b | $7.8b | |
| Property and equipment, at cost, less accumulated depreciation and amortization ($6,680 at December 31, 2025 and $5,809 at December 31, 2024) | $8.1b | $7.0b | $7.0b | $6.9b | $6.7b | $6.4b | $6.5b | $6.2b | $6.0b | $6.3b | |
| Property, Plant and Equipment, Net | $8.1b | $7.0b | $7.0b | — | — | — | — | — | — | — | |
| Goodwill | $7.4b | $7.0b | $7.3b | $7.3b | $8.8b | $9.3b | $10.1b | $10.3b | $10.7b | $11.2b | |
| Intangible Assets, Net (Excluding Goodwill) | $1.8b | $1.8b | $1.7b | $1.6b | $1.6b | $1.5b | $1.4b | $1.4b | $1.4b | $1.3b | |
| Other intangible assets, at cost, less accumulated amortization ($1,328 at December 31, 2025 and $1,288 at December 31, 2024) | $1.8b | $1.8b | $1.7b | $1.6b | $1.6b | $1.5b | $1.4b | $1.4b | $1.4b | $1.3b | |
| Operating Lease, Right-of-Use Asset | — | — | — | $912.0m | $1.1b | $1.0b | $1.1b | $1.1b | $1.0b | $1.1b | |
| Investments and other assets | $1.2b | $1.5b | $1.5b | $2.4b | $2.5b | $3.3b | $3.1b | $3.2b | $3.0b | $2.9b | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $2.9b | $2.6b | $2.6b | $2.7b | $2.7b | $2.8b | $2.9b | $2.9b | $2.5b | $2.6b | |
| Assets held for sale | $29.0m | $1.0b | $107.0m | $387.0m | $140.0m | $0 | $0 | $775.0m | $21.0m | $62.0m | |
| Deferred income taxes | $279.0m | $36.0m | $36.0m | $27.0m | $29.0m | $36.0m | $217.0m | $326.0m | $227.0m | $240.0m | |
| Professional and general liability reserves | $613.0m | $654.0m | $666.0m | $585.0m | $735.0m | $791.0m | $790.0m | $792.0m | $900.0m | $951.0m | |
| Liabilities held for sale | $9.0m | $480.0m | $43.0m | $44.0m | $70.0m | $0 | $0 | $69.0m | $13.0m | $0 | |
| Income tax payable | — | — | — | — | — | — | — | $23.0m | $18.0m | $0 | |
| Other current liabilities | $1.2b | $1.2b | $1.1b | $1.3b | $1.3b | $1.4b | $1.5b | $1.8b | $1.6b | $1.8b | |
| Defined benefit plan obligations | $626.0m | $536.0m | $521.0m | $560.0m | $497.0m | $421.0m | $331.0m | $335.0m | $298.0m | $245.0m | |
| Common stock in treasury, at cost, 71,660 shares at December 31, 2025 and 62,892 shares at December 31, 2024 | ($2.4b) | ($2.4b) | ($2.4b) | ($2.4b) | ($2.4b) | ($2.4b) | ($2.7b) | ($2.9b) | ($3.5b) | ($4.9b) | |
| AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax | — | $4.0m | $0 | — | — | — | — | — | — | — | |
| Total shareholders’ equity | $417.0m | ($147.0m) | ($119.0m) | ($371.0m) | $28.0m | $1.0b | $1.1b | $1.6b | $4.2b | $4.2b | |
| Total equity | $1.1b | $539.0m | $687.0m | $483.0m | $937.0m | $2.1b | $2.5b | $3.1b | $5.8b | $6.0b | |
| Assets | $24.7b | $23.4b | $22.4b | $23.4b | $27.1b | $27.6b | $27.2b | $28.3b | $28.9b | $29.7b | |
| Total assets | $24.7b | $23.4b | $22.4b | $23.4b | $27.1b | $27.6b | $27.2b | $28.3b | $28.9b | $29.7b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $159.0m | $188.0m | $201.0m | $207.0m | $204.0m | $204.0m | $214.0m | |
| Accounts Payable, Current | $1.3b | $1.2b | $1.2b | $1.2b | $1.2b | $1.3b | $1.5b | $1.4b | $1.3b | $1.4b | |
| Operating Lease, Liability, Noncurrent | — | — | — | $858.0m | $999.0m | $924.0m | $1.0b | $1.0b | $950.0m | $1.0b | |
| Current portion of long-term debt | $191.0m | $146.0m | $182.0m | $171.0m | $145.0m | $135.0m | $145.0m | $120.0m | $92.0m | $79.0m | |
| Accrued compensation and benefits | $872.0m | $848.0m | $838.0m | $877.0m | $942.0m | $896.0m | $778.0m | $930.0m | $899.0m | $858.0m | |
| Accrued interest payable | $210.0m | $256.0m | $240.0m | $245.0m | $248.0m | $203.0m | $213.0m | $200.0m | $149.0m | $81.0m | |
| Long-term debt, net of current portion | $15.1b | $14.8b | $14.6b | $14.6b | $15.6b | $15.5b | $14.9b | $14.9b | $13.1b | $13.1b | |
| Liabilities, Current | $4.0b | $4.3b | $3.9b | $4.2b | $4.8b | $5.1b | $4.5b | $4.8b | $4.3b | $4.5b | |
| Total current liabilities | $4.0b | $4.3b | $3.9b | $4.2b | $4.8b | $5.1b | $4.5b | $4.8b | $4.3b | $4.5b | |
| Deferred Income Tax Liabilities, Net | $279.0m | $36.0m | $36.0m | $27.0m | $29.0m | $36.0m | $217.0m | $326.0m | $227.0m | $240.0m | |
| Other Liabilities, Noncurrent | $610.0m | $631.0m | $578.0m | $1.4b | $1.6b | $1.4b | $1.8b | $1.7b | $1.6b | $1.7b | |
| Other long-term liabilities | $610.0m | $631.0m | $578.0m | $1.4b | $1.6b | $1.4b | $1.8b | $1.7b | $1.6b | $1.7b | |
| Deferred Tax Liabilities, Net | $1.4b | $858.0m | $753.0m | $767.0m | $1.3b | $1.3b | $1.2b | $1.2b | $1.1b | $1.2b | |
| Liabilities | $21.2b | $21.0b | $20.3b | $21.4b | $24.2b | $23.3b | $22.5b | $22.8b | $20.4b | $20.7b | |
| Total liabilities | $21.2b | $21.0b | $20.3b | $21.4b | $24.2b | $23.3b | $22.5b | $22.8b | $20.4b | $20.7b | |
| Redeemable Noncontrolling Interest, Equity, Carrying Amount | $2.4b | $1.9b | $1.4b | $1.5b | $2.0b | $2.2b | $2.1b | $2.4b | $2.7b | $3.0b | |
| Redeemable noncontrolling interests in equity of consolidated subsidiaries | $2.4b | $1.9b | $1.4b | $1.5b | $2.0b | $2.2b | $2.1b | $2.4b | $2.7b | $3.0b | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $7.0m | $7.0m | $7.0m | $7.0m | $7.0m | $8.0m | $8.0m | $8.0m | $8.0m | $8.0m | |
| Additional Paid in Capital | $4.8b | $4.9b | $4.7b | $4.8b | $4.8b | $4.9b | $4.8b | $4.8b | $4.9b | $4.9b | |
| Retained Earnings (Accumulated Deficit) | ($1.7b) | ($2.4b) | ($2.2b) | ($2.5b) | ($2.1b) | ($1.2b) | ($803.0m) | ($192.0m) | $3.0b | $4.4b | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($258.0m) | ($204.0m) | ($223.0m) | ($257.0m) | ($281.0m) | ($233.0m) | ($181.0m) | ($181.0m) | ($180.0m) | ($181.0m) | |
| Common stock, $0.05 par value; authorized 262,500 shares; 158,612 shares issued at December 31, 2025 and 158,001 shares issued at December 31, 2024 | $7.0m | $7.0m | $7.0m | $7.0m | $7.0m | $8.0m | $8.0m | $8.0m | $8.0m | $8.0m | |
| Accumulated other comprehensive loss | ($258.0m) | ($204.0m) | ($223.0m) | ($257.0m) | ($281.0m) | ($233.0m) | ($181.0m) | ($181.0m) | ($180.0m) | ($181.0m) | |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax | $205.0m | $170.0m | $223.0m | $257.0m | $281.0m | — | — | — | — | — | |
| Stockholders' Equity Attributable to Parent | $417.0m | ($147.0m) | ($119.0m) | ($371.0m) | $28.0m | $1.0b | $1.1b | $1.6b | $4.2b | $4.2b | |
| Stockholders' Equity Attributable to Noncontrolling Interest | $665.0m | $686.0m | $806.0m | $854.0m | $909.0m | $1.0b | $1.3b | $1.5b | $1.6b | $1.8b | |
| Noncontrolling interests | $665.0m | $686.0m | $806.0m | $854.0m | $909.0m | $1.0b | $1.3b | $1.5b | $1.6b | $1.8b | |
| Liabilities and Equity | $24.7b | $23.4b | $22.4b | $23.4b | $27.1b | $27.6b | $27.2b | $28.3b | $28.9b | $29.7b | |
| Total liabilities and equity | $24.7b | $23.4b | $22.4b | $23.4b | $27.1b | $27.6b | $27.2b | $28.3b | $28.9b | $29.7b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.